Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
HealthStream
HSTM
$840M
| $984K | ﹤0.01% |
44,425
+6,360
| +17% | +$147K |
|
2752
CALL
Teck Resources
TECK
$32.6B
| $984K | ﹤0.01% |
94,400
-81,300
| -46% | -$747K |
|
2753
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$438M
| $983K | ﹤0.01% |
9,900
| – | – |
|
2754
National Bank Holdings
NBHC
$1.9B
| $981K | ﹤0.01% |
36,367
+4,635
| +15% | +$118K |
|
2755
Jack in the Box
JACK
$335M
| $979K | ﹤0.01% |
13,209
+5,317
| +67% | +$328K |
|
2756
Coca-Cola Consolidated
COKE
$12.8B
| $977K | ﹤0.01% |
42,580
+2,040
| +5% | +$47.8K |
|
2757
M/I Homes
MHO
$3.84B
| $977K | ﹤0.01% |
28,369
-10,675
| -27% | -$292K |
|
2758
PUT
ProShares Ultra S&P500
SSO
$8.36B
| $976K | ﹤0.01% |
62,400
-117,600
| -65% | -$1.66M |
|
2759
PUT
Westlake Corp
WLK
$9.9B
| $976K | ﹤0.01% |
18,200
-53,400
| -75% | -$2.46M |
|
|
ABB
2760
DELISTED
ABB Ltd
ABB
| $976K | ﹤0.01% |
43,255
-174,467
| -80% | -$3.35M |
|
2761
CALL
VF Corp
VFC
$5.89B
| $975K | ﹤0.01% |
16,000
-20,600
| -56% | -$1.2M |
|
2762
Federal Agricultural Mortgage
AGM
$2.56B
| $973K | ﹤0.01% |
15,193
+2,760
| +22% | +$171K |
|
2763
PUT
Zoetis
ZTS
$30B
| $973K | ﹤0.01% |
7,100
-12,500
| -64% | -$1.63M |
|
|
CAMP
2764
DELISTED
CalAmp Corp.
CAMP
| $970K | ﹤0.01% |
5,265
+4,048
| +333% | +$625K |
|
|
NSTG
2765
DELISTED
NanoString Technologies, Inc.
NSTG
| $969K | ﹤0.01% |
33,046
+2,752
| +9% | +$82K |
|
|
CMA
2766
PUT
DELISTED
Comerica
CMA
| $968K | ﹤0.01% |
25,400
-32,900
| -56% | -$1.15M |
|
2767
PUT
Incyte
INCY
$24.4B
| $967K | ﹤0.01% |
9,300
-43,700
| -82% | -$4.21M |
|
2768
Patterson-UTI
PTEN
$3.76B
| $966K | ﹤0.01% |
278,157
-272,375
| -49% | -$939K |
|
2769
PUT
Moderna
MRNA
$23.6B
| $963K | ﹤0.01% |
+15,000
| New | +$821K |
|
2770
City Holding Co
CHCO
$2.04B
| $961K | ﹤0.01% |
14,746
+1,608
| +12% | +$102K |
|
2771
PUT
Yeti Holdings
YETI
$3.95B
| $961K | ﹤0.01% |
22,500
-43,700
| -66% | -$1.31M |
|
|
ALX
2772
Alexander's
ALX
$1.41B
| $960K | ﹤0.01% |
3,980
-928
| -19% | -$249K |
|
2773
PUT
ResMed
RMD
$30.7B
| $960K | ﹤0.01% |
5,000
-6,500
| -57% | -$1.06M |
|
2774
Autohome
ATHM
$2.62B
| $959K | ﹤0.01% |
12,706
-2,962
| -19% | -$232K |
|
|
VRTU
2775
DELISTED
Virtusa Corporation
VRTU
| $957K | ﹤0.01% |
29,471
+4,269
| +17% | +$132K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.